First Header Logo Second Header Logo

Search Results (68)

MatchTypeWhy
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.Academic Article Why?
Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases.Academic Article Why?
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients.Academic Article Why?
Intake of antioxidant nutrients and risk of non-Hodgkin's Lymphoma in the Women's Health Initiative.Academic Article Why?
Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma.Academic Article Why?
Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms.Academic Article Why?
Role of hematopoietic stem cell transplantation in the treatment of non-Hodgkin's lymphoma.Academic Article Why?
Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience.Academic Article Why?
Lymphoma, Non-HodgkinConcept Why?
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).Academic Article Why?
Automated colorimetric in situ hybridization (CISH) detection of immunoglobulin (Ig) light chain mRNA expression in plasma cell (PC) dyscrasias and non-Hodgkin lymphoma.Academic Article Why?
Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.Academic Article Why?
Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation.Academic Article Why?
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.Academic Article Why?
Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.Academic Article Why?
Per Page    Page  of 5last Nextnext
Prev
Search Criteria
  • Non Hodgkin Lymphoma
Filter by Type
_
Click "Why?" to see why an item matched the search.